Some of us may remember conferences with sessions entitled 'Why 3D?' Such sessions are a thing of the past now because there is an accumulating body of evidencejoined by the recent article from Leslie and colleagues [1] -demonstrating the importance and utility of 3D culture systems to discover and model biological process with in vivo relevance. For example, when normal and malignant human breast cells are placed in 3D cultures of laminin-rich gels, the former cells form growth-arrested, lumen-containing acini and the latter cells form disorganized structures [2] . Inhibitors of epidermal growth factor receptor and β 1 -integrin can 'revert' the malignant phenotype, and each inhibitor downmodulates its own target as well as the other targets only in 3D but not in cells grown as monolayer cultures -suggesting that signaling pathways reciprocally regulate each other to maintain the transformed state [3] . ErbB2/HER2-induced transformation of 3D structures, but not cell proliferation, requires disruption of the Par6 cell polarity pathway [4] . Th is requirement for deregu lation of cell polarity pathways is also observed during ErbB2-induced mammary tumori genesis in mouse models of human breast cancer [5] . Cells in a 3D matrix can thus provide novel and un expected insights into cancer biology.
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Leslie and colleagues demonstrate an unexpected role for the 3D context in regulating the ability of H-RasV12 to induce IL-6 and activate STAT3 [1] . Consistent with previous reports on the role played by STAT3 [6, 7] , the authors fi rst demonstrate that downregulation of STAT3 inhibits the ability of H-RasV12 to transform MCF-10A cells. While there was no increase in tyrosine phosphorylation of STAT3 when H-RasV12-transformed MCF-10A cells were grown as monolayer cultures, the authors surpris ingly observed a signifi cant increase in phospho-STAT3 and IL-6, a potent activator of STAT3 phosphorylation in tumors derived from H-RasV12transformed MCF-10A cells. In addition, spontaneous mouse mammary tumors induced by expression of K-Ras under the control of the mouse mammary tumor virus promoter also show an increase in phospho-Stat3 and IL-6.
Th ese observations suggest that STAT3 phosphorylation may be specifi c to the context in which cells are grown. Th e authors confi rm this possibility by demonstrating that Ras-transformed MCF-10A cells induce expression of IL-6 and activate STAT3 phosphorylation when cultured on a bed of Matrigel or Laminin matrix but not when grown as monolayer cultures [1] . To rule out the possibility that cells in monolayer cultures lost their ability to respond to IL-6, the authors treated the Ras-transformed cells with exogenous IL-6 and demonstrate that the cells possess the ability to induce STAT3 phosphorylation in response to IL-6. Th ey go on to demonstrate that the culture context is critical not only for the activation but also for maintenance of the Ras-IL-6-STAT3 signaling network. Culturing tumor cells from xenograft or Ras-driven primary mouse mammary tumors for a few passages as monolayers results in the cells losing their ability to both express IL-6 and induce phosphorylation of STAT3.
Th ese results, however, diff er from a previous report where H-RasV12-transformed SV-40 T/t-Ags and hTERT immortalized human mammary epithelial cells express
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The behavior of a cell is signifi cantly infl uenced by its context. Epithelial cells derived from glandular organs such as the breast recreate their glandular organization when grown under 3D culture conditions. While traditional monolayer cultures are powerful tools to understand how cells proliferate, grow and respond to stress, they do not recreate the 3D property observed in vivo. Multiple studies demonstrate that 3D organization can reveal novel and unexpected insights into the mechanisms by which normal and tumorderived epithelial cells function. In the present article we comment on a study that reports identifi cation of a RasV12-induced IL-6 signaling network in mammary epithelial cells in 3D cultures. IL-6 even in monolayer cultures [8] . It is possible that an explanation can be off ered by considering the diff erentiation status of MCF-10A and hTERT human mammary epithelial cells. Unlike hTERT immortalized human mammary epithelial cells, which consist of a mixture of cells with epithelial and mesenchymal morphology, the MCF-10A cells have a strict epithelial, cobblestone morphology. Epithelial cells and mesenchymal cells may respond diff erently to H-RasV12-induced activa tion of the IL-6-STAT3 path way. Mesenchymal cells may activate autocrine production of IL-6 in response to expression of oncogenic Ras, whereas epithelial cells do not. Interestingly, the authors show that activation of STAT3 leads to repression of E-cadherin expression and, conversely, inhibition of IL-6 or JAK restored expression of E-cadherin. It is possible that activation of the IL-6-STAT3 signaling pathway induces a loss of epithelial characteristics and pushes cells towards a mesenchymal state.
Consistent with this possibility, previous studies have shown that stimulation of breast cancer cell lines with exogenous IL-6 induces STAT3 activation and downregulation of E-cadherin to induce epithelial to mesenchymal transition [9] . Th is process can set up a feedforward loop where the presence of IL-6 in tumors, produced either by the cancer cells themselves or by immune cells in the tumor microenvironment, can induce tumor epithelial cells to transition to a diff eren tiation state that confers properties such as migration, invasion and resistance to therapy. Not entirely clear, however, is whether the presence of the mesenchymal state is suffi cient to couple Ras signaling to activation of the IL-6/ STAT3 pathway because K-RasV12-induced transformation of NIH3T3 cells does not induce phos phorylation of STAT3 [10] . Leslie and colleagues show that culturing epithelial cells in a 3D matrix or in vivo activates the right nodes in the intracellular signaling network that can now induce the Ras-IL-6-STAT3 net work. How is this achieved? A lot remains to be under stood.
Given that an increase in circulating IL-6 levels is strongly associated with poor clinical prognosis in patients with breast cancer [11] , and that autocrine production of IL-6 promotes multidrug resistance in breast cancer cells [11] , the mechanisms by which expression of IL-6 is regulated in breast cancer is of signifi cant clinical importance. Th e study by Leslie and colleagues further highlights the importance of culture context when investigating signaling networks in breast epithelial cells and emphasizes the importance of using in vivo and 3D culture models to verify and validate the observations made in monolayer cultures.
